跳轉至內容
Merck
全部照片(1)

文件

123040

Sigma-Aldrich

阿卡地新

AICA-Riboside, CAS 2627-69-2, is a cell-permeable nucleoside compound whose phosphorylated metabolite activates AMPK and acts as a regulator of de novo purine synthesis.

同義詞:

阿卡地新

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C9H14N4O5
CAS號碼:
分子量::
258.23
MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze

顏色

white to brown

溶解度

methanol: 10 mg/mL
water: soluble

運輸包裝

ambient

儲存溫度

2-8°C

InChI

1S/C9H14N4O5/c10-7-4(8(11)17)12-2-13(7)9-6(16)5(15)3(1-14)18-9/h2-3,5-6,9,14-16H,1,10H2,(H2,11,17)/t3-,5-,6-,9-/m1/s1

InChI 密鑰

RTRQQBHATOEIAF-UUOKFMHZSA-N

一般說明

一种在细胞内加工形成磷酸化代谢物的细胞渗透性嘧啶核苷化合物,该代谢物可激活腺苷一磷酸激活的蛋白激酶(AMPK),而不会破坏ATP、ADP或AMP的细胞浓度。还充当从头嘌呤合成的调节剂。刺激灌注和离体肌肉中的葡萄糖摄取。AICAr刺激的葡萄糖转运不受PI-3K抑制剂渥曼青霉素(目录编号681675)的影响。已显示可抑制三酰基甘油(TAG),二酰基甘油(DAG)和磷脂的合成,这可能是AMPK激活以及随后AMPK抑制sn-甘油-3-磷酸酰基转移酶(GPAT)的结果。还报道抑制Hsp90伴侣功能。提供针对葡萄糖剥夺、化学缺氧以及暴露于谷氨酸和淀粉样蛋白β(Aβ)肽引起的细胞死亡的保护。
一种细胞可渗透的嘧啶核苷化合物,其磷酸化代谢物激活单磷酸腺苷活化蛋白激酶(AMPK)并作为从头嘌呤合成的调节剂。刺激灌注和离体肌肉中的葡萄糖摄取。提供针对葡萄糖剥夺、化学缺氧以及暴露于谷氨酸和Aβ肽引起的细胞死亡的保护。

生化/生理作用

主要靶标
腺苷单磷酸激活蛋白激酶(AMPK)
产物不与ATP竞争。
可逆:否
细胞可渗透性:是

包裝

用惰性气体包装

警告

毒性:标准处理(A)

準備報告

可能需要加热到50°C才能完全溶解在甲醇中。

重構

在复溶后,分装并冷冻保存(-20°C)。储备溶液在-20°C下可稳定保存至多3个月。

其他說明

Meli, M., et al. 2006.J. Med. Chem.in press.
Culmsee, C., et al. 2001.J. Mol.Neurosci.17, 45.
Muoio, D.M., et al. 1999.Biochem.J.338, 783.
Hayashi, T., et al. 1998.Diabetes47, 1369.
Corton, J.M., et al. 1995.Eur. J. Biochem.229, 558.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Fansi Jin et al.
Allergy, 74(6), 1145-1156 (2018-12-20)
Nuclear receptor subfamily 4 group A member 1 (NR4A1), an orphan nuclear receptor, has been implicated in several biological events such as metabolism, apoptosis, and inflammation. Recent studies indicate a potential role for NR4A1 in mast cells, yet its role
Marta García-Juan et al.
Glia, 72(3), 588-606 (2023-11-27)
Proteostasis mechanisms mediated by macroautophagy/autophagy are altered in neurodegenerative diseases such as Alzheimer disease (AD) and their recovery/enhancement has been proposed as a therapeutic approach. From the two central nodes in the anabolism-catabolism balance, it is generally accepted that mechanistic
Yi-Ting Huang et al.
British journal of pharmacology, 181(15), 2429-2442 (2024-03-27)
The interleukin (IL)-36 pathway is a critical player in the pathogenesis of pustular psoriasis. However, therapies targeting this pathway are limited or unaffordable (e.g. the anti-IL-36 receptor antibody). AMP-activated protein kinase (AMPK), a regulator of cellular energy and metabolism, is
Irene Benito-Cuesta et al.
Autophagy, 17(3), 656-671 (2020-02-23)
The physiological AKT-MTORC1 and AMPK signaling pathways are considered key nodes in the regulation of anabolism-catabolism, and particularly of macroautophagy/autophagy. Indeed, it is reported that these are altered processes in neurodegenerative proteinopathies such as Alzheimer disease (AD), mainly characterized by

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務